Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2033
2.3 Market Size & Forecast, By Segmentation, 2022–2033
2.3.1 Market Size By Process
2.3.2 Market Size By Technology
2.3.3 Market Size By Drug Type
2.3.4 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Active Drug Discovery Programs
4.1.1 Global number of ongoing drug discovery programs (%)
4.1.2 Active programs by therapeutic area (oncology, neurology, rare diseases) (%)
4.1.3 Growth in the number of early-stage vs. late-stage discovery programs (%)
4.2 Technology Adoption Statistics
4.2.1 Percentage of discovery projects using high-throughput screening, AI, bioinformatics, genomics, or proteomics (%)
4.2.2 Annual growth rate of technology adoption in drug discovery pipelines (%)
4.2.3 Share of integrated AI/bioinformatics platforms across pharmaceutical and biotech companies (%)
4.3 Drug Type Distribution
4.3.1 Share of small molecules vs. biologics vs. advanced therapies (gene/cell therapies) (%)
4.3.2 Percentage of late-stage development programs for each drug type (%)
4.3.3 Growth trends in biologics and targeted therapy candidates in discovery pipelines (%)
4.4 End-User / Stakeholder Statistics
4.4.1 Number or share of pharmaceutical & biotechnology companies using discovery services (%)
4.4.2 Number or share of Contract Research Organizations (CROs) engaged in discovery programs (%)
4.4.3 Share of academic & research institutes contributing to global drug discovery projects (%)
5. Drug Discovery Market Segmental Analysis & Forecast, By Process, 2022 – 2033, Value (USD Billion)
5.1 Introduction
5.2 Target Identification & Validation
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2033
5.3 Hit-to-Lead Identification
5.4 Lead Optimization
5.5 Candidate Validation
5.6 Others
6. Drug Discovery Market Segmental Analysis & Forecast, By Technology, 2022 – 2033, Value (USD Billion)
6.1 Introduction
6.2 High-Throughput Screening
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2033
6.3 Bioinformatics
6.4 Molecular Modeling & Simulation
6.5 Genomics
6.6 Proteomics
6.7 Others
7. Drug Discovery Market Segmental Analysis & Forecast, By Drug Type, 2022 – 2033, Value (USD Billion)
7.1 Introduction
7.2 Small Molecules
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2033
7.3 Biologics
7.4 Others
8. Drug Discovery Market Segmental Analysis & Forecast, By End User, 2022 – 2033, Value (USD Billion)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2033
8.3 Contract Research Organizations (CROs)
8.4 Academic & Research Institutes
8.5 Others
9. Drug Discovery Market Segmental Analysis & Forecast By Region, 2022 – 2033, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Drug Discovery Market Size & Forecast, By Process, 2022 – 2033
9.2.3 Drug Discovery Market Size & Forecast, By Technology, 2022 – 2033
9.2.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022 – 2033
9.2.5 Drug Discovery Market Size & Forecast, By End User, 2022 – 2033
9.2.6 Drug Discovery Market Size & Forecast, By Country, 2022 – 2033
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Drug Discovery Market Size & Forecast, By Process, 2022 – 2033
9.3.3 Drug Discovery Market Size & Forecast, By Technology, 2022 – 2033
9.3.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022 – 2033
9.3.5 Drug Discovery Market Size & Forecast, By End User, 2022 – 2033
9.3.6 Drug Discovery Market Size & Forecast, By Country, 2022 – 2033
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Drug Discovery Market Size & Forecast, By Process, 2022 – 2033
9.4.3 Drug Discovery Market Size & Forecast, By Technology, 2022 – 2033
9.4.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022 – 2033
9.4.5 Drug Discovery Market Size & Forecast, By End User, 2022 – 2033
9.4.6 Drug Discovery Market Size & Forecast, By Country, 2022 – 2033
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Drug Discovery Market Size & Forecast, By Process, 2022 – 2033
9.5.3 Drug Discovery Market Size & Forecast, By Technology, 2022 – 2033
9.5.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022 – 2033
9.5.5 Drug Discovery Market Size & Forecast, By End User, 2022 – 2033
9.5.6 Drug Discovery Market Size & Forecast, By Country, 2022 – 2033
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Drug Discovery Market Size & Forecast, By Process, 2022 – 2033
9.6.3 Drug Discovery Market Size & Forecast, By Technology, 2022 – 2033
9.6.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022 – 2033
9.6.5 Drug Discovery Market Size & Forecast, By End User, 2022 – 2033
9.6.6 Drug Discovery Market Size & Forecast, By Country, 2022 – 2033
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022 – 2033
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Process/Service & Technology Benchmarking
10.4.1 Process/Service Specifications & Features By Key Players
10.4.2 Process/Service Heatmap By Key Players
10.4.3 Technology Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Eli Lilly
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Process/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Johnson & Johnson
10.6.3 AbbVie
10.6.4 Merck & Co.
10.6.5 Roche
10.6.6 Pfizer
10.6.7 AstraZeneca
10.6.8 Novartis
10.6.9 Bayer
10.6.10 GlaxoSmithKline (GSK)
10.6.11 Amgen
10.6.12 Sanofi
10.6.13 Bristol Myers Squibb
10.6.14 Abbott Laboratories
10.6.15 Gilead Sciences
10.6.16 Regeneron Pharmaceuticals
10.6.17 Vertex Pharmaceuticals
10.6.18 Eisai Co., Ltd.
10.6.19 Takeda Pharmaceutical Company
10.6.20 Biogen
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figure
